(Press-News.org)
UVA Health researchers have discovered a potential way to predict which patients with severe COVID-19 are likely to recover well and which are likely to suffer “long-haul” lung problems. That finding could help doctors better personalize treatments for individual patients.
UVA’s new research also alleviates concerns that severe COVID-19 could trigger relentless, ongoing lung scarring akin to the chronic lung disease known as idiopathic pulmonary fibrosis, the researchers report. That type of continuing lung damage would mean that patients’ ability to breathe would continue to worsen over time.
“We are excited to find that people with long-haul COVID have an immune system that is totally different from people who have lung scarring that doesn’t stop,” said researcher Catherine A. Bonham, MD, a pulmonary and critical care expert who serves as scientific director of UVA Health’s Interstitial Lung Disease Program. “This offers hope that even patients with the worst COVID do not have progressive scarring of the lung that leads to death.”
Long-Haul COVID-19
Up to 30% of patients hospitalized with severe COVID-19 continue to suffer persistent symptoms months after recovering from the virus. Many of these patients develop lung scarring – some early on in their hospitalization, and others within six months of their initial illness, prior research has found. Bonham and her collaborators wanted to better understand why this scarring occurs, to determine if it is similar to progressive pulmonary fibrosis and to see if there is a way to identify patients at risk.
To do this, the researchers followed 16 UVA Health patients who had survived severe COVID-19. Fourteen had been hospitalized and placed on a ventilator. All continued to have trouble breathing and suffered fatigue and abnormal lung function at their first outpatient checkup.
After six months, the researchers found that the patients could be divided into two groups: One group’s lung health improved, prompting the researchers to label them “early resolvers,” while the other group, dubbed “late resolvers,” continued to suffer lung problems and pulmonary fibrosis.
Looking at blood samples taken before the patients’ recovery began to diverge, the UVA team found that the late resolvers had significantly fewer immune cells known as monocytes circulating in their blood. These white blood cells play a critical role in our ability to fend off disease, and the cells were abnormally depleted in patients who continued to suffer lung problems compared both to those who recovered and healthy control subjects.
Further, the decrease in monocytes correlated with the severity of the patients’ ongoing symptoms. That suggests that doctors may be able to use a simple blood test to identify patients likely to become long-haulers -- and to improve their care.
“About half of the patients we examined still had lingering, bothersome symptoms and abnormal tests after six months,” Bonham said. “We were able to detect differences in their blood from the first visit, with fewer blood monocytes mapping to lower lung function.”
The researchers also wanted to determine if severe COVID-19 could cause progressive lung scarring as in idiopathic pulmonary fibrosis. They found that the two conditions had very different effects on immune cells, suggesting that even when the symptoms were similar, the underlying causes were very different. This held true even in patients with the most persistent long-haul COVID-19 symptoms. “Idiopathic pulmonary fibrosis is progressive and kills patients within three to five years,” Bonham said. “It was a relief to see that all our COVID patients, even those with long-haul symptoms, were not similar.”
Because of the small numbers of participants in UVA’s study, and because they were mostly male (for easier comparison with IPF, a disease that strikes mostly men), the researchers say larger, multi-center studies are needed to bear out the findings. But they are hopeful that their new discovery will provide doctors a useful tool to identify COVID-19 patients at risk for long-haul lung problems and help guide them to recovery.
“We are only beginning to understand the biology of how the immune system impacts pulmonary fibrosis,” Bonham said. “My team and I were humbled and grateful to work with the outstanding patients who made this study possible.”
Findings Published
The researchers have published their findings in the scientific journal Frontiers in Immunology. The research team consisted of Grace C. Bingham, Lyndsey M. Muehling, Chaofan Li, Yong Huang, Shwu-Fan Ma, Daniel Abebayehu, Imre Noth, Jie Sun, Judith A. Woodfolk, Thomas H. Barker and Bonham. Noth disclosed that he has received personal fees from Boehringer Ingelheim, Genentech and Confo unrelated to the research project. In addition, he has a patent pending related to idiopathic pulmonary fibrosis. Bonham and all other members of the research team had no financial conflicts to disclose.
The UVA research was supported by the National Institutes of Health, grants R21 AI160334 and U01 AI125056; NIH’s National Heart, Lung and Blood Institute, grants 5K23HL143135-04 and UG3HL145266; UVA’s Engineering in Medicine Seed Fund; the UVA Global Infectious Diseases Institute’s COVID-19 Rapid Response; a UVA Robert R. Wagner Fellowship; and a Sture G. Olsson Fellowship in Engineering.
To keep up with the latest medical research news from UVA, subscribe to the Making of Medicine blog at http://makingofmedicine.virginia.edu.
END
A new study from researchers at the Johns Hopkins Center for Gun Violence Solutions and Vanderbilt University found that an average of 1,769 people were injured annually in police shootings from 2015 to 2020, 55 percent of them or 979 people, fatally. The study covered a total of 10,308 incidents involving shootings by police. The Center is based at the Johns Hopkins Bloomberg School of Public Health.
The majority of victims in shootings by police—84 percent overall—were reported as armed with a firearm or other weapon, such as a knife or vehicle, during ...
The origin of COVID-19 is highly debated – most studies have focused on a zoonotic origin, but research from the journal Risk Analysis, examined the likelihood of an unnatural origin (i.e. from a laboratory.)
The results indicate a greater likelihood of an unnatural than natural origin of the virus. The researchers used an established risk analysis tool for differentiating natural and unnatural epidemics, the modified Grunow-Finke assessment tool (mGFT) to study the origin of COVID-19. This risk assessment cannot prove the specific origin of COVID-19 but shows that the possibility of a laboratory origin ...
By design, synthetic molecules typically have specific jobs to prevent or accelerate reactions between other molecules. To help control more complicated reactions, researchers may harness spare space in one molecule to synthesize another chemical structure. The host-guest assembly can better induce the specific desired reaction than either component individually — if the scientists designing the assembly get it right.
A multi-institution team based in China has reported a novel cluster — the guest — that nucleated ...
A research team, led by Professor Seok Ju Kang in the School of Energy and Chemical Engineering at UNIST, has unveiled a groundbreaking technique for mass-producing polymer solid electrolytes, crucial components in batteries.
Departing from the traditional melt casting method, the team introduced a horizontal centrifugal casting method to overcome existing limitations. This innovative approach has redefined the production process for high-quality polymer solid electrolytes, revolutionizing the industry.
Drawing inspiration from the horizontal centrifugal casting technique used in producing iron pipes, the research team successfully achieved a uniform polymer ...
HOUSTON – (March 15, 2024) – Materials scientists at Rice University are shedding light on the intricate growth processes of 2D crystals, paving the way for controlled synthesis of these materials with unprecedented precision.
Two-dimensional materials such as graphene and molybdenum disulfide (MoS2) exhibit unique properties that hold immense promise for applications in electronics, sensors, energy storage, biomedicine and more. However, their complex growth mechanisms — inconsistent correlations ...
MINNEAPOLIS/ST. PAUL (03/15/2024) — For the first time, researchers at the University of Minnesota Twin Cities showed that non-invasive brain stimulation can change a specific brain mechanism that is directly related to human behavior. This is a major step forward for discovering new therapies to treat brain disorders such as schizophrenia, depression, Alzheimer’s disease, and Parkinson’s disease.
The study was recently published in Nature Communications, a peer-reviewed, open ...
WASHINGTON – A rigorous analysis of numerous studies concludes that a part of the brain traditionally associated with movement is abnormal in children with developmental language impairments, according to Georgetown University Medical Center neuroscientists. The discovery has the potential to improve both the diagnosis and treatment of the language difficulties.
The researchers investigated brain abnormalities in developmental language disorder. This condition, which impacts the development of various aspects of language, is about as common as attention-deficit/hyperactivity ...
By Benjamin Boettner
(BOSTON) — Therapeutic cancer vaccines are a form of immunotherapy in the making that could not only destroy cancer cells in patients, but keep a cancer from coming back and spreading. Multiple therapeutic cancer vaccines are being studied in clinical trials, but despite their promise, they are not routinely used yet by clinical oncologists to treat their patients.
The central ingredient of therapeutic cancer vaccines is antigens, which are preferentially produced or newly produced (neoantigens) by tumor cells and enable a patient’s immune system to search and destroy the cancerous ...
A printable organic polymer that assembles into chiral structures when printed has enabled researchers to reliably measure the amount of charge produced in spin-to-charge conversion within a spintronic material at room temperature. The polymer’s tunable qualities and versatility make it desirable not only for less expensive, environmentally friendly, printable electronic applications, but also for use in understanding chirality and spin interactions more generally.
Spintronic devices are electronic devices that harness the spin of an electron, ...
For Immediate Release
OAKLAND, Calif., March 15, 2024 — Innovation in trauma-informed health care is the core focus of a special section in today’s issue of The Permanente Journal. The special section features 13 articles that touch on this increasingly prominent approach and reaches into several diverse subdomains such as mental health, physical health, body size diversity and systems-level implementation. Workplace wellness, clinician training and medical school curricula related to trauma are also covered in the issue.
Trauma-informed health care has grown ...
